Danish physician and founder of Nordisk Insulinlaboratorium (the Novo Nordisk precursor) who developed protamine insulin — the longer-acting formulation — and is credited with founding one half of what became Novo Nordisk, while forcing out his business partner Thorvald Pedersen.
Developed NPH insulin (protamine insulin) — a longer-acting formulation that didn't require injection before every meal — dramatically improving diabetes management, and built the Nordisk research infrastructure that eventually merged with Novo to form Novo Nordisk.
Discussing
Ask anything about Hans Christian Hagedorn — their ideas, influences, contradictions, legacy.
Sign in to start a conversation.